<DOC>
	<DOC>NCT00280059</DOC>
	<brief_summary>The purpose of this study is to assess whether Lyrica is a safe and effective treatment for partial epilepsy in comparison with an established treatment, Lamictal.</brief_summary>
	<brief_title>Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy</brief_title>
	<detailed_description />
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Patients must be diagnosed with partial epilepsy and have experienced at least 2 partial seizures (simple partial, complex partial or partial seizure with secondary generalization) in the past year with one in the past 6 months. Treatable causes of seizures, for example identified etiologies including metabolic, neoplastic or active infectious origin. Primary generalized seizures.</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Epilepsy</keyword>
	<keyword>partial seizures</keyword>
	<keyword>pregabalin monotherapy</keyword>
	<keyword>lamotrigine comparator</keyword>
	<keyword>double-blind and randomized trial</keyword>
</DOC>